Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMID 9175062)

Published in Nephrol Dial Transplant on May 01, 1997

Authors

W Y Tse1, A J Howie, D Adu, C O Savage, N T Richards, D C Wheeler, J Michael

Author Affiliations

1: Department of Nephrology, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.

Articles citing this

Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. Clin J Am Soc Nephrol (2009) 1.79

MPO-ANCA associated crescentic glomerulonephritis with numerous immune complexes: case report. BMC Nephrol (2012) 0.99

A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy. BMC Nephrol (2013) 0.95

Membranous nephropathy associated with familial chronic ulcerative colitis in a 12-year-old girl. Pediatr Nephrol (2005) 0.83

Membranous glomerulopathy with superimposed pauci-immune necrotizing crescentic glomerulonephritis. Clin Kidney J (2012) 0.82

Rapidly deteriorating kidney function in a young man previously diagnosed with membranous nephropathy. Nephron Clin Pract (2010) 0.82

Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome. Springerplus (2015) 0.78

Membranous Nephropathy With MPO-ANCA-Associated Crescentic GN. Nephrourol Mon (2014) 0.75

A case presenting with the possible relationship between myeloperoxidase-antineutrophil cytoplasmic antibody-associated glomerulonephritis and membranous changes of the glomerular basement membrane. CEN Case Rep (2012) 0.75

A case of membranous nephropathy and myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Exp Ther Med (2014) 0.75

Necrotizing and crescentic glomerulonephritis with membranous nephropathy in a patient exposed to levamisole-adulterated cocaine. Clin Kidney J (2015) 0.75

A Case of Membranous Glomerulonephritis with Superimposed Anti-Neutrophil Cytoplasmic Antibody-Associated Rapidly Progressive Crescentic Glomerulonephritis. Chonnam Med J (2015) 0.75

Clinical and Immunologic Characteristics of Patients With ANCA-Associated Glomerulonephritis Combined With Membranous Nephropathy: A Retrospective Cohort Study in a Single Chinese Center. Medicine (Baltimore) (2015) 0.75

Membranous nephropathy with crescents in a patient with Hashimoto's thyroiditis: a case report. Medicine (Baltimore) (2014) 0.75

A Case of Concurrent MPO-/PR3-Negative ANCA-Associated Glomerulonephritis and Membranous Glomerulopathy. Case Rep Nephrol (2015) 0.75

Antineutrophil cytoplasmic antibody-associated glomerulonephritis with immunoglobulin deposition. Clin Exp Nephrol (2016) 0.75

Articles by these authors

Distinguishing between discriminative and motivational functions of stimuli. J Exp Anal Behav (1982) 30.61

Flight from behavior analysis. Behav Anal (1980) 7.82

Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int (2007) 7.75

Establishing operations. Behav Anal (1993) 7.48

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM (1994) 5.23

Implementation of rules based computerised bedside prescribing and administration: intervention study. BMJ (2000) 5.23

The benefits of Skinner's analysis of verbal behavior for children with autism. Behav Modif (2001) 5.18

Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab (2001) 4.47

Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet (1987) 4.20

International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Am J Clin Pathol (1999) 3.31

Association of alkaline phosphatase with an autoantigen recognised by circulating anti-neutrophil antibodies in systemic vasculitis. Lancet (1987) 2.85

The discriminative stimulus or S(D). Behav Anal (1980) 2.64

The effect of depression on return to drinking: a prospective study. Arch Gen Psychiatry (1998) 2.46

Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med (1985) 2.46

Verbal behavior. J Exp Anal Behav (1984) 2.46

The role of automatic reinforcement in early language acquisition. Anal Verbal Behav (1996) 2.42

Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum (1997) 2.31

Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM (2007) 2.14

Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Kidney Int (1999) 2.10

The evidence base for the treatment of lupus nephritis in the new millennium. Nephrol Dial Transplant (2001) 2.04

Primary systemic vasculitis. Lancet (1997) 1.94

Current research on the influence of establishing operations on behavior in applied settings. J Appl Behav Anal (2000) 1.79

Classical versus non-renal Wegener's granulomatosis. Q J Med (1994) 1.79

Skinner's elementary verbal relations: Some new categories. VB News (1982) 1.78

Pathogenesis of ANCA-associated systemic vasculitis. J Pathol (2000) 1.78

Establishing operations and the mand. Anal Verbal Behav (1988) 1.77

The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant (2001) 1.75

Renal pathological findings in infective endocarditis. Nephrol Dial Transplant (2000) 1.74

Automatic reinforcement and automatic punishment in infant vocal behavior. Anal Verbal Behav (1996) 1.73

Two kinds of verbal behavior plus a possible third. Anal Verbal Behav (1985) 1.71

Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int (2001) 1.67

Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. Br Med J (Clin Res Ed) (1986) 1.65

Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis (2001) 1.64

The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party. Q J Med (1990) 1.62

Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus. Nephrol Dial Transplant (1992) 1.54

Non-steroidal anti-inflammatory drugs and renal failure. Lancet (1986) 1.52

Recurrent haematuria: role of renal biopsy and investigative morbidity. Br Med J (1976) 1.51

Anti-ssDNA and antinuclear antibodies in human malaria. Clin Exp Immunol (1982) 1.49

Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol (1999) 1.47

Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM (2000) 1.44

Hypercalcaemia: changing causes over the past 10 years. BMJ (1992) 1.43

Abnormalities of endothelial function in patients with predialysis renal failure. Heart (2000) 1.43

Amyloidosis in continuous ambulatory peritoneal dialysis. Postgrad Med J (1987) 1.39

Endothelial cell antibodies: pathogenetic or epiphenomenon? Nephrol Dial Transplant (1994) 1.39

High versus "low" dose corticosteroids in recipients of cadaveric kidneys: prospective controlled trial. Br Med J (Clin Res Ed) (1983) 1.34

IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Invest (1996) 1.34

The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int (2006) 1.30

Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction. J Exp Med (1990) 1.30

Improving prescribing using a rule based prescribing system. Qual Saf Health Care (2004) 1.29

European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus (2009) 1.28

ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients. Rheumatology (Oxford) (2004) 1.27

Rapid diagnosis of obscure pneumonia in immunosuppressed renal patients by cytology of alveolar lavage fluid. Lancet (1983) 1.27

Relapses in patients with a systemic vasculitis. Q J Med (1993) 1.27

Treatment of rolling neutrophils with antineutrophil cytoplasmic antibodies causes conversion to firm integrin-mediated adhesion. Arthritis Rheum (2000) 1.26

Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma. J Med Genet (1995) 1.26

IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis. Clin Exp Immunol (1996) 1.26

Antineutrophil cytoplasmic antibodies induce reactive oxygen-dependent dysregulation of primed neutrophil apoptosis and clearance by macrophages. Am J Pathol (2000) 1.24

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant (2004) 1.23

Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab (1998) 1.23

Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. QJM (1997) 1.22

Knowledge of renal histology alters patient management in over 40% of cases. Nephrol Dial Transplant (1994) 1.20

Scanning and transmission electron microscopy on the epithelium of human palatine tonsils. J Pathol (1980) 1.20

Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrol Dial Transplant (2001) 1.20

Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant (1991) 1.18

11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod (1998) 1.18

Polyarteritis and the kidney. Q J Med (1987) 1.16

The endothelial cell as a regulator of T-cell function. Immunol Rev (1990) 1.16

Clinical and immunological evolution of oligoanuric anti-GBM nephritis treated by haemodialysis. Lancet (1986) 1.16

An optical practice based diabetic eye screening programme. Diabet Med (1995) 1.16

Widespread distribution in human tissues of an antigenic determinant of granulocytes. J Clin Pathol (1984) 1.15

Objective monitoring of disease activity in polyarteritis by measurement of serum C reactive protein concentration. Br Med J (Clin Res Ed) (1984) 1.14

Expression of type 2 11beta-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life. J Clin Endocrinol Metab (1998) 1.13

Can graft endothelial cells initiate a host anti-graft immune response? Transplantation (1996) 1.12

Sulphasalazine induced renal failure. Gut (1992) 1.12

Spontaneous remissions of nephrotic syndrome in renal amyloidosis. Br Med J (1978) 1.12